The Virginia General Assembly is in full swing, and lawmakers have already considered several marijuana policy reform bills. Sen. Adam Ebbin’s SB 1091 — which would end the automatic six-month driver’s license suspension for first offense possession of marijuana — was approved by the Senate on Friday.

Last year, the General Assembly approved a bill to allow in-state production of cannabidiol oil for patients with intractable epilepsy. However, to become law, that bill — Sen. Dave Marsden’s SB 1027 — needs to pass again this year. It passed the Senate on Jan. 26.

Companion legislation for both bills are now being considered in the House.

Unfortunately, the committee defeated two other bills, which would have decriminalized possession of marijuana — replacing possible jail time with a civil penalty.

Read more

A new bill, HB 157, has been introduced in Wyoming by Rep. Mark Baker (R-Sweetwater) and a bipartisan group of legislators that would eliminate criminal penalties for possession of small amounts of marijuana. This would avoid branding someone with a lifelong criminal record for using a substance that is safer than alcohol.

HB 157 would apply to up to three ounces of cannabis or marijuana products (such as edibles) containing 500 milligrams or less of THC. Under current Wyoming law, possession of even a tiny amount of marijuana carries a penalty of up to one year of incarceration and a fine of up to $1,000. Rep. Baker’s bill would reduce the penalty to a civil fine of up to $200.

If you are a Wyoming resident, please ask your legislators to stop arresting people for cannabis so law enforcement can focus on violent crime.

Read more

Read more

On Friday, we received a clear indication of what to expect from the Massachusetts Legislature in the next few months. Politicians introduced a number of bills that would adversely impact the implementation of Question 4 and restrict the new law’s home cultivation and personal possession limits.

Legislators have filed bills that would push back sales of edibles by two years, reduce home grow and personal possession limits, give local officials the power to block marijuana establishments, unnecessarily restructure the Cannabis Control Commission, and increase the legal age limit to 25.

These are clear attempts to reverse the will of the 1.8 million voters who approved Question 4.

If you are a Massachusetts resident, please contact your lawmakers and tell them that you oppose any attempts to significantly alter Question 4, including those listed above.

Read more

Tuesday morning, the Florida Health Department released draft rules that are supposed to implement the medical marijuana law approved by 71% of Florida voters. It doesn’t appear regulators actually read Amendment 2, however. Instead, they tried to simply slightly expand the existing, and ineffective, low-THC program.

These rules would be a disaster for patients:

• They require doctors to “order” specific quantities of cannabis, which is too much like an unlawful prescription and puts them at risk under federal law. If doctors don’t participate, patients won’t be able to enroll.
• They give the Health Department — not the patient’s doctor — the ability to determine whether the patient’s condition is “substantially similar” to those listed in the amendment.
• They continue the oligopoly of only seven businesses for an expected patient population of over 162,000 — far fewer businesses per patient than any other state! This will drive up prices and result in less variety of strains and products for different patients’ needs.
• Even if additional businesses were eventually allowed, they would be subject to unfair and onerous requirements.

Thankfully, these rules are not final and the public has an opportunity to comment. There will be a series of public meetings around the state, and members of the public can provide comments on the Department of Health website.

Read more

The North Dakota Senate unanimously passed S.B. 2154 on Tuesday, which blocks the implementation of Measure 5 until either July or until a new replacement medical marijuana law goes into effect. Now, the bill heads to the House.

Unless representatives hear their constituents oppose this delay, S.B. 2154 is likely to pass. Lawmakers need to heed the will of the voters, 64% of whom passed Measure 5 last November. Many patients can’t afford to wait. Perhaps more alarming still is the bill’s implication that the Legislature may replace voters’ medical marijuana bill. All signs show that any substitution would limit patients’ rights or possibly even be unworkable.

If you are a North Dakota resident, please ask your representative to stand up for patients and to vote NO on S.B. 2154!

Read more

The National Academies of Sciences released a report on the health impacts of marijuana Thursday, confirming the existence of medical benefits and dispelling some long-held myths about the substance.

The review of more than 10,000 scientific abstracts found, “There is conclusive or substantial evidence that cannabis or cannabinoids are effective” for the treatment of chronic pain in adults, chemotherapy-induced nausea and vomiting, and multiple sclerosis spasticity.

The report also dispels several myths about the health impacts of marijuana. It found no links between smoking marijuana and the development of lung, head, or neck cancers, nor did it establish a link between marijuana use and asthma or other respiratory diseases. The respiratory problems that it did link to smoking marijuana, such as bronchitis, appear to improve after the consumer ceases their use.

According to the report, “There is no or insufficient evidence” linking marijuana use to all-cause mortality (death), deaths from overdose, or occupational accidents or injuries. It also found no substantial evidence of a link between the use of marijuana and the use of other illegal drugs. The report also does not appear to make any links between marijuana use and violent or aggressive behavior. Several of these findings were also included in the National Academies of Sciences’ previous report on marijuana, which was released in 1999.

Read more